Gundogan G, Kig C, Karacan M, Dogruman H
Turk J Pharm Sci. 2021; 18(2):185-191.
PMID: 33902257
PMC: 8100783.
DOI: 10.4274/tjps.galenos.2020.58827.
Islam S, Aboussekhra A
J Exp Clin Cancer Res. 2019; 38(1):382.
PMID: 31470883
PMC: 6716935.
DOI: 10.1186/s13046-019-1360-3.
Andersson Y, Haavardtun S, Davidson B, Dorum A, Fleten K, Fodstad O
Oncotarget. 2017; 8(37):61800-61809.
PMID: 28977905
PMC: 5617465.
DOI: 10.18632/oncotarget.18694.
Cosme B, Falagan-Lotsch P, Ribeiro M, Napoleao K, Granjeiro J, Moura-Neto R
In Vitro Cell Dev Biol Anim. 2017; 53(5):430-434.
PMID: 28127703
DOI: 10.1007/s11626-016-0124-z.
Hernandez L, Kim M, Lyle L, Bunch K, House C, Ning F
Gynecol Oncol. 2016; 142(2):332-40.
PMID: 27235858
PMC: 4961516.
DOI: 10.1016/j.ygyno.2016.05.028.
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.
Crane E, Kwan S, Izaguirre D, Tsang Y, Mullany L, Zu Z
PLoS One. 2015; 10(8):e0135101.
PMID: 26248031
PMC: 4527847.
DOI: 10.1371/journal.pone.0135101.
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes.
Beaufort C, Helmijr J, Piskorz A, Hoogstraat M, Ruigrok-Ritstier K, Besselink N
PLoS One. 2014; 9(9):e103988.
PMID: 25230021
PMC: 4167545.
DOI: 10.1371/journal.pone.0103988.
Epithelial ovarian cancer experimental models.
Lengyel E, Burdette J, Kenny H, Matei D, Pilrose J, Haluska P
Oncogene. 2013; 33(28):3619-33.
PMID: 23934194
PMC: 3990646.
DOI: 10.1038/onc.2013.321.
Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary.
Yamada T, Kanda T, Mori H, Shimokawa K, Kagawa M, Shibayama Y
J Ovarian Res. 2013; 6(1):8.
PMID: 23379414
PMC: 3568727.
DOI: 10.1186/1757-2215-6-8.
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3.
Fu S, Li Y, Huang J, Liu T, Hong Z, Chen A
Cancer Biol Ther. 2012; 13(11):1034-41.
PMID: 22895067
PMC: 3461810.
DOI: 10.4161/cbt.21045.
Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells.
Bezler M, Hengstler J, Ullrich A
Mol Oncol. 2012; 6(5):516-29.
PMID: 22841590
PMC: 5528396.
DOI: 10.1016/j.molonc.2012.07.001.
Xenograft and Transgenic Mouse Models of Epithelial Ovarian Cancer and Non Invasive Imaging Modalities to Monitor Ovarian Tumor Growth In situ -Applications in Evaluating Novel Therapeutic Agents.
Connolly D, Hensley H
Curr Protoc Pharmacol. 2010; 45:14.12.1-14.12.26.
PMID: 20634901
PMC: 2904083.
Comparative proteomic study of two closely related ovarian endometrioid adenocarcinoma cell lines using cIEF fractionation and pathway analysis.
Dai L, Li C, Shedden K, Misek D, Lubman D
Electrophoresis. 2009; 30(7):1119-31.
PMID: 19288585
PMC: 2674123.
DOI: 10.1002/elps.200800505.
rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition.
Melichar B, Hu W, Patenia R, Melicharova K, Gallardo S, Freedman R
J Transl Med. 2003; 1(1):5.
PMID: 14572312
PMC: 222988.
DOI: 10.1186/1479-5876-1-5.
Organotypic culture of human ovarian surface epithelial cells: a potential model for ovarian carcinogenesis.
Gregoire L, Munkarah A, Rabah R, Morris R, Lancaster W
In Vitro Cell Dev Biol Anim. 1998; 34(8):636-9.
PMID: 9769148
DOI: 10.1007/s11626-996-0012-z.
Genetic instability in human ovarian cancer cell lines.
Orth K, Hung J, Gazdar A, Bowcock A, Mathis J, Sambrook J
Proc Natl Acad Sci U S A. 1994; 91(20):9495-9.
PMID: 7937795
PMC: 44839.
DOI: 10.1073/pnas.91.20.9495.
Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.
Freedman R, Bowen J, Atkinson E, Scott W, Wagner S
Cancer Immunol Immunother. 1984; 17(2):142-6.
PMID: 6088033
PMC: 11039087.
DOI: 10.1007/BF00200051.
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H
Arch Gynecol Obstet. 1988; 243(2):69-81.
PMID: 3165255
DOI: 10.1007/BF00932972.
Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2 (Sf) growing in serum-free conditions: growth characteristics, biochemical, and cytogenetic studies.
Golombick T, Dansey R, Bezwoda W, Rosendorff J
In Vitro Cell Dev Biol. 1990; 26(5):447-54.
PMID: 2351639
DOI: 10.1007/BF02624086.
